Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Medical Hematology Analyzer market in this environment.
In terms of revenue, this research report indicated that the global Medical Hematology Analyzer market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Medical Hematology Analyzer industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Sysmex Corporation aims at producing XX K Units Medical Hematology Analyzer in 2020, with XX % production to take place in global market, Beckman Coulter, Inc. accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Medical Hematology Analyzer Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Medical Hematology Analyzer Market
Sysmex Corporation
Beckman Coulter, Inc.
Abbott Laboratories
Siemens Healthcare
Bayer
HORIBA ABX SAS
A.S.L
Boule Diagnostics AB
Research and Production Complex "Biopromin" Ltd
Mindray
Sinnowa
Hui Zhikang
Jinan Hanfang
Gelite
Sinothinker
Bio-Rad Laboratories
Nihon Kohden
Abaxis
...
Major Type of Medical Hematology Analyzer Covered in Prudent Markets report:
Automatic Hematology Analyzers
Semiautomatic Hematology Analyzers
Application Segments Covered in Prudent Markets Market
Hospital
Laboratory
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Medical Hematology Analyzer Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Automatic Hematology Analyzers -Product Introduction and Major Manufacturers
1.1.2 Semiautomatic Hematology Analyzers -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Medical Hematology Analyzer Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Medical Hematology Analyzer Market
3.1.1 Top Companies leading Medical Hematology Analyzer Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Medical Hematology Analyzer Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Medical Hematology Analyzer Market
3.2.1 Top Companies leading Medical Hematology Analyzer Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Medical Hematology Analyzer Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Medical Hematology Analyzer Market
3.3.1 Top Companies leading Medical Hematology Analyzer Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Medical Hematology Analyzer Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Medical Hematology Analyzer Market
3.4.1 Top Companies leading Medical Hematology Analyzer Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Medical Hematology Analyzer Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Medical Hematology Analyzer Market
3.5.1 Top Companies leading Medical Hematology Analyzer Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Medical Hematology Analyzer Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Medical Hematology Analyzer Market
3.6.1 Top Companies leading Medical Hematology Analyzer Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Medical Hematology Analyzer Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Medical Hematology Analyzer Market
3.7.1 Top Companies leading Medical Hematology Analyzer Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Medical Hematology Analyzer Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Medical Hematology Analyzer Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Medical Hematology Analyzer Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Medical Hematology Analyzer Sales and Growth Rate (2021-2027)
5.2 Global Medical Hematology Analyzer Sales Value and Growth Rate (2021-2027)
6 Medical Hematology Analyzer Competitive Analysis
6.1 Sysmex Corporation
6.1.1 Sysmex Corporation Company Profiles
6.1.2 Sysmex Corporation Product Introduction
6.1.3 Sysmex Corporation Medical Hematology Analyzer Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Beckman Coulter, Inc.
6.2.1 Beckman Coulter, Inc. Company Profiles
6.2.2 Beckman Coulter, Inc. Product Introduction
6.2.3 Beckman Coulter, Inc. Medical Hematology Analyzer Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Company Profiles
6.3.2 Abbott Laboratories Product Introduction
6.3.3 Abbott Laboratories Medical Hematology Analyzer Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Company Profiles
6.4.2 Siemens Healthcare Product Introduction
6.4.3 Siemens Healthcare Medical Hematology Analyzer Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Bayer
6.5.1 Bayer Company Profiles
6.5.2 Bayer Product Introduction
6.5.3 Bayer Medical Hematology Analyzer Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 HORIBA ABX SAS
6.6.1 HORIBA ABX SAS Company Profiles
6.6.2 HORIBA ABX SAS Product Introduction
6.6.3 HORIBA ABX SAS Medical Hematology Analyzer Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 A.S.L
6.7.1 A.S.L Company Profiles
6.7.2 A.S.L Product Introduction
6.7.3 A.S.L Medical Hematology Analyzer Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Boule Diagnostics AB
6.8.1 Boule Diagnostics AB Company Profiles
6.8.2 Boule Diagnostics AB Product Introduction
6.8.3 Boule Diagnostics AB Medical Hematology Analyzer Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Research and Production Complex "Biopromin" Ltd
6.9.1 Research and Production Complex "Biopromin" Ltd Company Profiles
6.9.2 Research and Production Complex "Biopromin" Ltd Product Introduction
6.9.3 Research and Production Complex "Biopromin" Ltd Medical Hematology Analyzer Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Mindray
6.10.1 Mindray Company Profiles
6.10.2 Mindray Product Introduction
6.10.3 Mindray Medical Hematology Analyzer Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Sinnowa
6.12 Hui Zhikang
6.13 Jinan Hanfang
6.14 Gelite
6.15 Sinothinker
6.16 Bio-Rad Laboratories
6.17 Nihon Kohden
6.18 Abaxis
7 Conclusion